Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Miroslava Bosheva"'
Autor:
Miroslava Bosheva, Istvan Tokodi, Aleksander Krasnow, Helle Krogh Pedersen, Oksana Lukjancenko, Aron C. Eklund, Dominik Grathwohl, Norbert Sprenger, Bernard Berger, Colin I. Cercamondi, HMO Study Investigator Consortium, Viktor Bauer, Malgorzata Arciszewska, Maria Tarneva, Irina Popova, Svilen Dosev, Sirma Dimitrova, Olga Nikolova, Marzena Nowak, Magdalena Szuflinska-Sidorowicz, Bartosz Korczowski, Rositsa Karcheva-Beloeva, Stefan Banov, Boguslawa Cimoszko, Wieslaw Olechowski, Robert Simko, Zsuzsanna Tengelyi, Piotr Korbal, Marta Zolnowska, Anton Bilev, Georgios Vasilopoulos, Sylwia Korzynska, István Laki, Margarita Koleva-Syarova, Toni Grigorov, Steliyana Kraeva, Éva Kovács, Rada Markova, Grazyna Jasieniak-Pinis, Katalin Fister, Tatyana Stoeva
Publikováno v:
Frontiers in Nutrition, Vol 9 (2022)
BackgroundHuman milk oligosaccharides (HMOs) have important biological functions for a healthy development in early life.ObjectiveThis study aimed to investigate gut maturation effects of an infant formula containing five HMOs (2′-fucosyllactose, 2
Externí odkaz:
https://doaj.org/article/b764f824794a45aaa6aed13c8af2214a
Autor:
Neofit Spasov, Diana Dimitrova-Popova, Nikoleta Traikova-Djambazova, Mariya Spasova, Miroslava Bosheva
Publikováno v:
Folia Medica, Vol 62, Iss 4, Pp 762-768 (2020)
Introduction: Blood-induced joint damage as a hallmark of haemophilia continues to occur despite the widespread prophylaxis. Pre-cise assessment and follow-up of joint status are crucial for tailoring their treatment. Aim: To study the correlation be
Externí odkaz:
https://doaj.org/article/68e87f092c1046fea5fdf1a1de7cecfb
Publikováno v:
Therapeutic Advances in Respiratory Disease, Vol 12 (2018)
Background: The efficacy and safety of fluticasone propionate/formoterol fumarate pressurized metered-dose inhaler (pMDI) (fluticasone/formoterol; Flutiform ® ; 100/10 µg b.i.d.) was compared with fluticasone propionate (Flixotide ® Evohaler ® pM
Externí odkaz:
https://doaj.org/article/26bdc797c91747a4895dfc8a6d6b06b1
Autor:
Eric A F Simões, Shabir A Madhi, William J Muller, Victoria Atanasova, Miroslava Bosheva, Fernando Cabañas, Manuel Baca Cots, Joseph B Domachowske, Maria L Garcia-Garcia, Ineta Grantina, Kim A Nguyen, Heather J Zar, Anna Berglind, Celeste Cummings, M Pamela Griffin, Therese Takas, Yuan Yuan, Ulrika Wählby Hamrén, Amanda Leach, Tonya Villafana
Publikováno v:
The Lancet Child & Adolescent Health. 7:180-189
Autor:
Laura L, Hammitt, Ron, Dagan, Yuan, Yuan, Manuel, Baca Cots, Miroslava, Bosheva, Shabir A, Madhi, William J, Muller, Heather J, Zar, Dennis, Brooks, Amy, Grenham, Ulrika, Wählby Hamrén, Vaishali S, Mankad, Pin, Ren, Therese, Takas, Michael E, Abram, Amanda, Leach, M Pamela, Griffin, Tonya, Villafana, Jon, Heinrichs
Publikováno v:
New England Journal of Medicine. 386:837-846
BACKGROUND: Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract infection and hospitalization in infants. Nirsevimab is a monoclonal antibody to the RSV fusion protein that has an extended half-life. The efficacy and safety
Autor:
Rima Snariene, Hans Georg Münch, Anne Smits, Christopher M. Rubino, Arunas Liubsys, Karine Litherland, Tomasz Tomasik, Kamal Hamed, Dace Gardovska, Chi D. Hornik, Mark J Polak, Przemko Kwinta, Veerle Cossey, Sebastian Schröpf, Christine Ruehle, Miroslava Bosheva
Publikováno v:
The Pediatric Infectious Disease Journal
Pediatric infectious disease journal, Philadelphia : Lippincott Williams and Wilkins, 2021, vol. 40, no. 11, p. 997-1003
Pediatric infectious disease journal, Philadelphia : Lippincott Williams and Wilkins, 2021, vol. 40, no. 11, p. 997-1003
Supplemental Digital Content is available in the text.
Background: Ceftobiprole, the active moiety of the prodrug ceftobiprole medocaril, is an advanced-generation, broad-spectrum, intravenous cephalosporin, which is currently approved for the t
Background: Ceftobiprole, the active moiety of the prodrug ceftobiprole medocaril, is an advanced-generation, broad-spectrum, intravenous cephalosporin, which is currently approved for the t
Autor:
Jennifer I. Smart, Éva Károly, Mikael Saulay, Agnes Nemeth, Rusudan Gujabidze, Kamal Hamed, Miroslava Bosheva
Publikováno v:
The Pediatric Infectious Disease Journal
Supplemental Digital Content is available in the text.
Background: The advanced-generation, broad-spectrum, intravenous (IV) cephalosporin, ceftobiprole, is an effective and well-tolerated treatment for adults with hospital-acquired pneumonia (H
Background: The advanced-generation, broad-spectrum, intravenous (IV) cephalosporin, ceftobiprole, is an effective and well-tolerated treatment for adults with hospital-acquired pneumonia (H
Autor:
Nikoleta Traikova-Djambazova, Miroslava Bosheva, Mariya I. Spasova, Diana Dimitrova-Popova, Neofit Spasov
Publikováno v:
Folia Medica, Vol 62, Iss 4, Pp 762-768 (2020)
Introduction: Blood-induced joint damage as a hallmark of haemophilia continues to occur despite the widespread prophylaxis. Pre-cise assessment and follow-up of joint status are crucial for tailoring their treatment. Aim: To study the correlation be
Autor:
Laura Hammitt, Ron Dagan, Yuan Yuan, Manuel Baca Cots, Miroslava Bosheva, Shabhir A Mahdi, William J Muller, Heather J Zar, Dennis Brooks, Amy Grenham, Ulrika Wählby Hamrén, Vaishali S Mankad, Pin Ren, Therese Takas, Jon Heinrichs, Amanda Leach, M Pamela Griffin, Tonya L Villafana
Publikováno v:
Open Forum Infectious Diseases
Background Respiratory syncytial virus (RSV) is the most common cause of lower respiratory tract infection (LRTI) in infants. Nirsevimab is a single-dose monoclonal antibody with extended half-life that was shown to protect preterm infants 29 to < 35
Autor:
Steve Cunningham, Pedro A Piedra, Federico Martinon-Torres, Henryk Szymanski, Benedicte Brackeva, Evelyne Dombrecht, Laurent Detalle, Carmen Fleurinck, Pedra A Piedra, Stijn Verhulst, Inge Matthijs, Marijke Proesmans, Tessa Goetghebuer, Miroslava Bosheva, Svilen Dosev, Olga Nikolova, Petranka Chakarova, Elba Wu Hupat, Juan Mesa Monsalve, Mirjana Turkalj, Natasa Mesaric Antoncic, Goran Tesovic, Mirna SIPL, Blazenka Kljaic Bukvic, Irena Ivkovic-Jurekovic, Biserka Cicak, Sylva Skalova, Gerd Horneff, Christian Vogelberg, Éva Gacs, Krisztina Kalocsai, Anna Madarasi, Lajos Kovacs, Zoltan Novak, Zsolt Bene, Shai Ashkenazi, Aviv Goldbart, Lea Bentur, Nadezda Kolosa, Dace Gardovska, Poh Guan Khaw, Teck Hock Toh, Jessie Anne De Bruyne, Kah Kee Tan, Edison Alberto, Benjamin, Junior Sablan, Anjanette de Leon, Miroslav Repko, Karol Kralinsky, Ignacio Salamanca de la Cueva, Carlos Rodrigo Gonzalo de Liria, Federico Martinón-Torres, María Pilar Cedena Romero, Emilio Monteagudo Montesinos, Jamaree Teeratakulpisarn, Thanyawee Puthanakit, Peninnah Oberdorfer, Boonyarat Warachit
Background: Respiratory syncytial virus (RSV) is the most common cause of severe lower respiratory tract infection, with a high global health burden. There are no effective treatments available. ALX- 0171 is a novel trivalent Nanobody with antiviral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca5872490f3a29c13728dff2bd1f3999
https://www.bib.irb.hr/1091343
https://www.bib.irb.hr/1091343